Speaking up is so important for anyone going through a chronic illness like MS. Being a self-advocate while going through MS can be so challenging, as individuals going through MS are often misunderstood. This misunderstanding often stems from the invisible … Continue reading → Source:…
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…
Tweet The documents that dictate how a drug is used is called the “label” or the “summary of product characteristics” in Europe or UK. Yesterday, there was a post about biosimilar natalizumab (Tyruko) and reference natailizumab (Tysabri). In the highlights of the paper ( Gelissen…
Tweet When the patent of reference natalizumab (Tysabri) infusion ran out the makers brought out subcutaneous natalizumab (Tysabri) and encouraged the neuros to switch…It also allowed generic makers to make replicas of natalizumab, called a biosimilar because it isn’t identical. Along came the first biosimilar…
In recognition of Multiple Sclerosis Awareness Month in March, the MS Awareness Month campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…
In recognition of Multiple Sclerosis Awareness Month in March, the MS Community Spotlight campaign features a series of stories highlighting the real-life experiences of people affected by MS, written in their own words. Follow us on Facebook, Instagram, X, and Pinterest for more stories like…
Tweet The wearing off effect also known to some as the “CRAP gap” is something that occurs when you get to the end of your treatment cycle. But what is it? AI says “The “wearing-off” effect (WOE) of monoclonal antibodies (MAbs) is a commonly reported…
A combination of drugs widely used in anti-aging studies seems to compromise the function of the brain’s myelin-making cells and cause profound myelin loss, according to the findings of a new study in mice and lab-grown cells. The dual treatment, which combines dasatinib and quercetin,…
Al trabajar en la Asociación de Esclerosis Múltiple de América (MSAA, por sus siglas en inglés), a menudo me preguntan si tengo un diagnóstico de esclerosis múltiple (EM). Aun cuando la EM no forma parte de mi historia personal, convivir … Continue reading → Source:…
Working at the Multiple Sclerosis Association of America (MSAA), I am often asked if I have a diagnosis of multiple sclerosis (MS). While MS is not part of my personal journey, speaking with people living with MS has given me … Continue reading → Source:…